These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Determination of drug susceptibility and DNA fingerprint patterns of clinical isolates of Mycobacterium tuberculosis from Kampala, Uganda. Joloba ML, Whalen CC, Cave DM, Eisenach KD, Johnson JL, Okwera A, Morrissey A, Bajaksouzian S, Feagin J, Mugerwa R, Ellner J, Jacobs MR. East Afr Med J; 2000 Feb; 77(2):111-5. PubMed ID: 10774085 [Abstract] [Full Text] [Related]
25. Instability of tuberculin and Candida skin test reactivity in HIV-infected Ugandans. The Uganda-Case Western Reserve University Research Collaboration. Johnson JL, Nyole S, Okwera A, Whalen CC, Nsubuga P, Pekovic V, Huebner R, Wallis RS, Mugyenyi PN, Mugerwa RD, Ellner JJ. Am J Respir Crit Care Med; 1998 Dec; 158(6):1790-6. PubMed ID: 9847269 [Abstract] [Full Text] [Related]
27. Effect of isoniazid prophylaxis on incidence of active tuberculosis among Thai HIV-infected individuals. Saenghirunvattana S. J Med Assoc Thai; 1996 May; 79(5):285-7. PubMed ID: 8708519 [Abstract] [Full Text] [Related]
32. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis]. Saito W, Nagayama N, Miyamoto M, Hara H, Suzuki J, Masuda K, Baba M, Tamura A, Nagai H, Akagawa S, Kawabe Y, Machida K, Kurashima A, Yotsumoto H. Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568 [Abstract] [Full Text] [Related]
37. [The epidemiology of tuberculosis and of the resistance to antitubercular agents]. Aït Khaled N, Enarson D, Billo N. Rev Mal Respir; 1997 Dec; 14 Suppl 5():S8-18. PubMed ID: 9496587 [Abstract] [Full Text] [Related]
38. Tuberculin skin test and chemoprophylaxis of tuberculosis. Ortona L, Fantoni M. Rays; 1998 Dec; 23(1):218-24. PubMed ID: 9673147 [Abstract] [Full Text] [Related]